# SS-31 and MOTS-C: The Mitochondrial Stack Guide
Mitochondrial decline starts in your 30s and accelerates from there. By the time most people feel it — fatigue that doesn't resolve with sleep, slower recovery, mental fog — the underlying dysfunction has been building for years.
SS-31 (elamipretide) and MOTS-C address this from two different angles. They're not redundant — they're complementary. This guide breaks down how each works, how to introduce them, and what you can realistically expect from running both.
---
What SS-31 Does
SS-31 is a mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2). It binds to cardiolipin — a phospholipid embedded in the inner mitochondrial membrane that's essential for electron transport chain (ETC) function.
When mitochondria are under oxidative stress (from aging, high training volume, chronic illness, or metabolic dysfunction), cardiolipin gets oxidized and the ETC slows. ATP production drops. ROS (reactive oxygen species) increase. The mitochondria start signaling apoptosis.
SS-31 stabilizes cardiolipin and restores ETC function. The clinical research is actually extensive — SS-31 has been tested in heart failure (NEJM-published trial), ischemia-reperfusion injury, kidney disease, and age-related muscle loss. It's one of the few research peptides with meaningful human trial data.
What users typically report:
- Better stamina and reduced fatigue at training loads that previously felt hard
- Faster recovery between sessions
- Clearer thinking, especially in the afternoon
- Some notice improved sleep quality
- Dose: 5–10mg per day, subQ
- Timing: morning (energy-focused) or pre-workout
- Cycle: 4–8 weeks, 2–4 week break, reassess
- Improved endurance and aerobic capacity
- Better fat oxidation (noticeable during cardio)
- Reduced energy crashes between meals
- Metabolic clarity — body handles fuel more efficiently
- Dose: 5–10mg per week (split as 500mcg daily or 1mg every other day)
- Higher doses (10–15mg/week) used in heavy endurance athletes
- Timing: morning, daily or EOD
- Cycle: 4–8 weeks, 2–4 week break
- Confirm you're tolerating it well (injection site reactions are occasionally reported)
- Get a baseline sense of your energy and recovery before MOTS-C is added
- Avoid confounding — if you feel great (or off) after week 1, you'll know which compound to attribute it to
- Week 1: SS-31 only, 5mg/day subQ
- Weeks 2–5: SS-31 (5–10mg/day) + MOTS-C (500mcg daily or 1mg EOD)
- Week 6+: Continue both or assess what's driving results and adjust
Standard protocol:
---
What MOTS-C Does
MOTS-C is a mitochondria-derived peptide encoded in the mitochondrial genome itself — specifically the 12S rRNA. It acts as a metabolic signaling molecule, upregulating AMPK activity and improving insulin sensitivity.
Where SS-31 protects and repairs existing mitochondrial infrastructure, MOTS-C improves how cells handle energy substrates — particularly fat oxidation. AMPK activation redirects fuel utilization toward fat burning at rest and during low-intensity activity (Zone 2 cardio territory).
MOTS-C also appears to improve muscle glucose uptake independently of insulin, which is relevant for anyone doing body recomposition alongside a GLP-1 like Reta.
What users typically report:
Standard protocol:
---
Do You Need to Start SS-31 First?
This is the most common question when starting both. The short answer: you don't have to, but there's logic to it.
Starting SS-31 alone for 1–2 weeks lets you:
Alternatively, you can run both from day 1. They work through different pathways and there's no pharmacological reason to stagger. If you've already taken either before, starting together is fine.
Recommended approach for first-time users:
---
Running This Stack Alongside Semaglutide or Reta
GLP-1 agonists (semaglutide, tirzepatide, retatrutide) already improve metabolic efficiency by reducing caloric intake, improving insulin sensitivity, and decreasing systemic inflammation. MOTS-C adds to this — AMPK activation and improved fat oxidation compound on the metabolic improvements from GLP-1.
For someone on a microdose of semaglutide for inflammation specifically (not high-dose weight loss), MOTS-C is a logical addition. You're targeting inflammation from the GLP-1 side and mitochondrial metabolic function from the MOTS-C side — different mechanisms.
SS-31 is also appropriate alongside GLP-1 use — particularly if the primary driver is longevity/cellular health rather than just weight loss.
No known interactions between SS-31, MOTS-C, and GLP-1 agonists. Running all three is well-tolerated in practice.
---
Stack Summary
| Compound | Mechanism | Primary Benefit | Dose | Timing |
|---|---|---|---|---|
| SS-31 | Cardiolipin stabilization / ETC protection | Cellular energy, recovery, ROS reduction | 5–10mg/day | Morning or pre-workout |
| MOTS-C | AMPK activation / fat oxidation | Endurance, metabolic efficiency, recomp | 5–10mg/week | Morning daily or EOD |
---
What to Expect (Realistic Timeline)
Week 1–2: Subtle shifts — some people notice less afternoon fatigue, slightly better workout recovery. Don't expect dramatic changes yet.
Week 2–4: More consistent energy through the day, improved performance on sustained cardio, reduced DOMS between sessions.
Week 4–8: Cumulative improvements in body composition (especially if combined with adequate protein and Zone 2 cardio), better sleep quality for many users, clearer cognitive baseline.
This stack is not a stimulant. It won't give you an immediate hit. The mechanism is cellular repair and metabolic optimization — that takes weeks to show up meaningfully.
---
Frequently Asked Questions
Q: Can I inject SS-31 and MOTS-C in the same syringe?
Yes — they can be drawn into the same syringe for a single injection if both are in aqueous solution. Keep them stored in separate vials.
Q: Can I stack this with NAD+ or Glutathione?
Absolutely. NAD+ (NMN, NR, or IV) supports the same mitochondrial energy pathways and adds sirtuin activation to the stack. Glutathione adds antioxidant support. These four together are an aggressive but well-supported longevity protocol.
Q: Is MOTS-C or SS-31 better for endurance athletes?
For pure endurance (high weekly volume), MOTS-C has the edge — the AMPK/fat oxidation mechanism directly improves performance at aerobic paces. SS-31's ROS protection is additive, especially at high training loads where mitochondrial damage accumulates.
Q: Are there any side effects to watch for?
SS-31: mild injection site irritation in some users, otherwise very clean profile. MOTS-C: minimal reported sides. Neither is immunosuppressive or hormonal.
Q: How do I know it's working?
Track your fatigue, workout recovery, and aerobic performance in PeptIQ. The changes are gradual — having a log to compare against week 1 makes the difference visible.
---
Track This Stack With PeptIQ
MOTS-C and SS-31 both require consistent timing to get maximum benefit. PeptIQ lets you log each compound, set daily reminders, and monitor how your energy and recovery trends over the course of a cycle.
Download PeptIQ — Premium; annual includes a 3-day trial.
